2026-10-25
Ingersoll Rand clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,990 +1.35%
S&P 7,377 +0.31%
GOLD $4,075 −0.94%
BTC $75,624 −0.16%
VIX 25.64 −9.01%
latest tape · as of 02:03 UTC
The Screen · Industrials · Specialty Industrial Machinery
Ingersoll Rand
IR · a US exchange · USD · Market cap $31.1B · 21,000 employees
Ingersoll Rand Inc.
Not yet scored82.99 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 02:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price82.99 USD at the 6 Nov 2026 close
- Our value readFair vs our fair value, as of 6 Nov 2026
- Our regime readMarkup, as of 7 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans slightly to calls (put/call 0.86)
- Last reviewed6 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $73.80 to $98.42, base estimate $85.58 (screen dated 2026-11-06).
- Trend Markup
- Insiders insiders sold, $831,470, latest filing 2026-11-05
- Positioning political selling, disclosed 2026-09-11
- Options put/call open interest 0.86, read 2026-11-07
- Ethical screen not yet scored
Price82.99 USD
Fair value85.58
Ethical score86.2/100
Value readFairas of 6 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup84.18-1.4% to today Distribution gives way to Markup after an 8% rise in 12 days
2026-10-24Read Distribution77.78+6.7% to today Accumulation gives way to Distribution
2026-10-11Read Accumulation76.38+8.7% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown76.38+8.7% to today Distribution gives way to Markdown after a 5% slide in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
Ingersoll Rand holds its Markup at $82.99. The statistical read favours the sellers, held for 7 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 7 days |
| Price at the screen | $82.99 |
| Valuation | 32.94 trailing · 20.48 forward price to earnings |
| Values screen | Not scored · score 86.2 |
| Beta | 1.15 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 26.50% | Below 33% | Interest-bearing debt is just 26.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 15.12% | Below 49% | Money owed to the company is 15.1% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Ingersoll Rand clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Ingersoll Rand clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 6 Nov 2026: it trades at roughly a 3% discount to our $85.58 fair value, narrow competitive moat, 8.50% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 3.0% discount to the base estimate.
Third-party analyst targets: 13 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $85.58, with a range of $73.80 to $98.42, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsIngersoll Rand trades near fair value with thin upside
Picture a reliable supplier of pumps and compressors that keeps factories and hospitals running. Ingersoll Rand sits just 3 percent above our fair value at 82 dollars, offering almost no margin of safety. A 21 times forward multiple on 8 percent revenue growth and a 6 percent return on equity simply does not clear the bar, even though the business passes our ethical screen.
The narrow moat and modest profit margin of 8 percent leave little room for error. Analysts like the name and point to a 92 dollar target, yet our reading of the same numbers says the shares are already priced fairly. We pass.
Cyclical demand in industrial end markets can swing sharply with any slowdown in manufacturing or energy spending. That exposure, combined with limited pricing power, keeps the opportunity rating at avoid. Analysis, not advice.
| Forward P/E | 20.5xexpensive even after accounting for its growth |
| Trailing P/E | 32.9xa premium valuation |
| EPS, trailing | 2.43 |
| EPS, forward | 3.91 |
| Revenue growth | +8.5%steady growth |
| Profit margin | 12.1%thin but positive margins |
| Return on equity | 9.5%a modest return on shareholder capital |
| FCF yield | 3.57% |
| Dividend yield | 0.11% |
| Debt to equity | 0.48minimal debt: a conservative balance sheet |
| Current ratio | 1.62healthy short-term liquidity |
| Beta | 1.15moves a little more than the market |
| Short interest, float | 0.04% |
| 52-week range | 68.07 - 100.96 |
| Moat | NARROW |
| Market cap | $31.1B |
| Employees | 21,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeIR trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Markup · changed $84.18
+14.6% Entry 17
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94.
2026-10-29
Distribution $73.48
-5.5% Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Distribution $77.78
+0.0% Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Distribution $77.78
+0.0% Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Distribution $77.78
+0.0% Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Distribution $77.78
+0.0% Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Distribution · changed $77.78
+0.0% Entry 11
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Accumulation $77.78
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Accumulation $77.78
+0.0% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18
Accumulation $77.78
+1.8% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (15 analysts) rates it buy, with a mean price target of $94.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Earnings Beat Could Be A Game Changer For Ingersoll Rand Stock (IR) Yahoo Finance · 7d ago
- Ingersoll Rand (IR) Q3 Results Spotlight M And A Progress Gap Yahoo Finance · 8d ago
- Ingersoll Rand (IR) Stock May Be 14% Undervalued As Buyback Expands Yahoo Finance · 8d ago
- What Ingersoll Rand (IR) Said on Its Q3 Earnings Call Yahoo Finance · 8d ago
- Ingersoll Rand (IR) Q3 2026 Earnings Call Transcript Yahoo Finance · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
OTISOtis Worldwide
DOVDover Corporation
SYMSymbotic Inc
XYLXylem Inc.
SDVKYSandvik AB (publ)
ROKRockwell Automation
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-05 | Schiesl Andrew R | See Remarks | S - Sale | 9,782 | $831,470 |
| 2026-05-05 | SWANENBURG MICHELLE | Director | 1,876 | · | |
| 2026-04-13 | REYNAL VICENTE | Chief Executive Officer | 30,492 | $2,683,296 | |
| 2026-04-13 | REYNAL VICENTE | Chief Executive Officer | 30,492 | $323,520 | |
| 2026-03-02 | REYNAL VICENTE | Chief Executive Officer | 118,044 | $11,109,121 | |
| 2026-03-02 | REYNAL VICENTE | Chief Executive Officer | 118,044 | $1,252,447 | |
| 2026-02-27 | KINI VIKRAM | Chief Financial Officer | 3,597 | · | |
| 2026-02-27 | KEENE KATHLEEN M | Officer | 1,236 | · | |
| 2026-02-27 | EMMERICH MATTHEW J | Chief Technology Officer | 643 | · | |
| 2026-02-27 | REYNAL VICENTE | Chief Executive Officer | 13,058 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-15 | Pete Sessions | Republican | sell | 15K–50K |
| 2026-10-09 | David Taylor | Republican | buy | 1K–15K |
| 2026-10-09 | David Taylor | Republican | buy | 1K–15K |
| 2026-10-09 | David Taylor | Republican | buy | 1K–15K |
| 2026-09-29 | Gil Cisneros | Democrat | sell | 100K–250K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $74.68 | -5.6% | $0.02 | $944 | -5.6% |
| 2 months | $85.36 | -17.4% | $0.02 | $826 | -17.4% |
| 3 months | $81.15 | -13.1% | $0.02 | $869 | -13.1% |
| 6 months | $83.40 | -15.5% | $0.04 | $846 | -15.4% |
| 1 year | $84.62 | -16.7% | $0.08 | $834 | -16.6% |
| 2 years | $91.02 | -22.6% | $0.16 | $776 | -22.4% |
| 3 years | $62.28 | +13.2% | $0.24 | $1,136 | +13.6% |
| 5 years | $47.68 | +47.8% | $0.38 | $1,486 | +48.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever IR does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.